Efficacy of deloratadine citrate disodium tablets combined with vitamin D drops against chronic idiopathic urticaria

LANG Xiaoqing; XU Fengfeng; GUO Shuping

PDF(704 KB)

Medical Journal of the Chinese People Armed Police Forces ›› 2020, Vol. 31 ›› Issue (7) : 561-564.

ORIGINAL ARTICLES

Efficacy of deloratadine citrate disodium tablets combined with vitamin D drops against chronic idiopathic urticaria

LANG Xiaoqing¹, XU Fengfeng¹, GUO Shuping²

Author information +

History +

Abstract

Objective To observe the clinical efficacy of desloratadine citrate disodium tablets combined with vitamin D drops against chronic spontaneous urticaria patients with serum 25- (OH) VD deficiency.Methods One hundred and eight outpatients with chronic spontaneous urticaria complicated with a deficiency of serum 25- (OH) VD content who were treated in the Dermatology Department of the First Hospital of Shanxi Medical University between October 2018 and September 2019 were divided into two groups using the random number table method: the control group (54 cases) that was given oral desloratadine citrate disodium tablets alone, and the observation group (54 cases) that was treated with oral desloratadine citrate disodium tablets combined with vitamin D drops. The course of treatment was 6 weeks. The total effective rate of patients, daily episode number scores, daily episode time scores, Dermatological Quality of Life Index (DLQI) scores and serum 25-(OH)VD content before and after treatment were compared between the two groups.Results The total effective rate in the observation group after treatment was 83.33%, higher than that in the control group (64.81%). The difference between the two groups was statistically significant(P＜0.05). After treatment, the mean serum 25-(OH)VD content[(59.43±10.08)nmol/L] in the observation group was significantly different from that of the control group[(30.19±9.60)nmol/L](P＜0.05).Conclusions In the clinical treatment of chronic spontaneous urticaria patients with a deficiency of serum 25- (OH) VD content , oral deloratadine citrate disodium tablets alone or in combination with vitamin D drops have good curative effect, but the latter approach is more effective in that it can significantly improve the therapeutic effect and patients’ quality of life, which should be made more accessible in future clinical use.

Key words

deloratadine citrate tablets / vitamin D drops / 25-(OH)VD content / chronic spontaneous urticaria / curative effect observation

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LANG Xiaoqing, XU Fengfeng, GUO Shuping. Efficacy of deloratadine citrate disodium tablets combined with vitamin D drops against chronic idiopathic urticaria[J]. Medical Journal of the Chinese People Armed Police Forces. 2020, 31(7): 561-564

References

[1] Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria[J]. Allergy,2018, 73(7):1393-1414.
[2] Kocatürk E, Maurer M, Metz M, et al. Looking forward to new targeted treatments for chronic spontaneous urticaria[J]. Clin Transl Allergy,2017,4(3) :7 -11.
[3] Boonpiyathad T,Pradubpongsa P,Sangasapaviriya A.Vitamin D supplements improve urticaria symptoms and quality of life in chronic spontaneous urticaria patients: a prospective case-control study[J]. Derm-Endocrinol, 2016, 8(1): e983685.
[4] Rorie A,Goldner W S , Lyden E, et al.Beneficial role for supplemental vitamin D3 treatment in chronic urticaria: a randomized study[J]. Annals of Allergy,2014,112(4):376-382.
[5] 王建英, 冯金鸽. NB-UVB联合盐酸西替利嗪治疗慢性荨麻疹的疗效和安全性[J]. 武警医学, 2018,29(9):56-58.
[6] Grzanka A, Machura E, Mazur B, et al. Relationship between vitamin D status and the inflammatory state in patients with chronic spontaneous urticaria[J]. J Inflammation, 2014, 11(1):2.
[7] Souberbielle J C. Epidemiology of vitamin-D deficiency[J]. Geriatr Psychol Neuropsychiatr Vieil, 2016, 14(1):7-15.
[8] Husein-El Ahmed H. Management of acne vulgaris with hormonal therapies in adult female patients [J]. Dermatol Ther,2015,28:166-168.
[9] Chang T W,Chen C,Lin C J,et al.The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria[J]. J Allergy and Clin Immunol,2015, 135(2):337-342.
[10] 中华医学会皮肤性病学分会荨麻疹研究中心.中国荨麻疹诊疗指南(2018版)[J]. 中华皮肤科杂志,2019,52(1):1-5.
[11] 徐道华.第三代抗组胺药地氯雷他定[J]. 中国新药杂志,2005,23(12):1486-1488.
[12] 袁华刚,冯兴华,张庆,等. 枸地氯雷他定长疗程递减服药法治疗慢性荨麻疹效果观察[J]. 中国乡村医药,2013,20(17):33-39.
[13] Devereaux B M, Leblanc J K, Kesler K,et al. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine h1 receptor antagonist 2nd communication: lack of central nervous system and cardiovascular effects[J]. Arzneimittelforschung, 2000,50(5):441-448.
[14] 沈萃萃,吕萌. 慢性荨麻疹患者血清25羟基维生素D水平变化及其与Th1/Th2细胞失衡的关系[J]. 山东医药,2018(4):77-79.
[15] Cousens L P, Najafian N, Mingozzi F, et al. In vitro and in vivo studies of igg-derived treg epitopes (tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity[J]. J Clin Immun,2013,33(1 Suppl):43-49.
[16] Sadeghi K,Wessner B,Laggner U,et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns[J]. Eur J Immunol, 2006, 36(2):361-370.
[17] Wang S F, Gao X Q,Xu Y N,et al. Elevated plasma level of interferon-λ1 in chronic spontaneous urticaria: upregulated expression in CD8(+) and epithelial cells and induction of inflammatory cell accumulation[J]. Mediators Inflamm, 2016,15(3):20-51.
[18] Mohammed J,Gunderson A J,Khong H H, et al. TGFβ₁ Overexpression by keratinocytes alters skin dendritic cell homeostasis and enhances contact hypersensitivity[J]. J Invest Dermatol, 2013, 133(1):135-143.
[19] Sindher,Sunit J,Jeffrey G,et al.Resolution of chronic urticaria coincident with vitamin D supplementation[J]. Ann Allergy Asthma Immunol,2012,109(5):125.
[20] 易红,宋玉杰,雷铁池,等.补充维生素D₃协同第二代抗组胺药物治疗慢性自发性荨麻疹的临床疗效观察和作用机制研究[J].中国麻风皮肤病杂志, 2019,14(3):144-147.